Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
15.38 USD | +0.36% | +2.47% | -50.91% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-50.91% | 2.53B | |
+57.51% | 59.34B | |
+43.17% | 40.24B | |
-5.22% | 39.88B | |
-5.56% | 28.55B | |
+15.38% | 27.26B | |
-21.08% | 19.23B | |
+33.28% | 12.61B | |
+2.26% | 12.49B | |
+25.79% | 12.28B |
- Stock Market
- Equities
- ACAD Stock
- News ACADIA Pharmaceuticals Inc.
- Acadia Pharmaceuticals to Conduct DAFFODILTM, A Clinical Study of Trofinetide